Showing results 3 to 6 of 6
< previous
Title | Author(s) | Issue Date | |
---|---|---|---|
Cost-Effectiveness of PDL1 Based Test-And-Treat Strategy with Pembrolizumab as the 1st Line Treatment for NSCLC in Hong Kong Proceeding/Conference:Journal of Thoracic Oncology | 2017 | ||
The Hong Kong consensus statements on unresectable hepatocellular carcinoma: narrative review and update for 2021 Journal:Hepatobiliary Surgery and Nutrition | 1-Jun-2023 | ||
2021 | |||
行政法 Book:香港法概論 | 2009 |